CoJourney Inc. Secures $30 Million Financing and Announces Expansion of US Operations: High Quality, Cost Effective, Commercial Scale Manufacturing Platform for Cell and Gene Therapies

PHILADELPHIA–(BUSINESS WIRE)– #biotechnology–CoJourney Inc. a global innovator in manufacturing and development of cell and gene therapies is pleased to announce completion of a $30 M Series A financing and expansion of its US organization and commercial manufacturing capabilities. This funding round was led by Legend Holdings and supported by GL…
Click here to view original post

Advertisement — Advertise with Biotech Networks